Nuveen
QTRX icon

Nuveen’s Quanterix QTRX Stock Holding History

Nuveen’s Portfolio QTRX Stock Details QTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
232,592
+160,750
+224% +$521K ﹤0.01% 2937
2026
Q1 		$253K Buy
71,842
+387
+0.5% +$2.26K ﹤0.01% 3041
2025
Q4 		$454K Hold
71,455
– – ﹤0.01% 2911
2025
Q3 		$388K Hold
71,455
– – ﹤0.01% 2982
2025
Q2 		$475K Sell
71,455
-343,923
-83% -$1.92M ﹤0.01% 2899
2025
Q1 		$2.7M Sell
415,378
-123,715
-23% -$1.03M ﹤0.01% 2206
2024
Q4 		$5.73M Sell
539,093
-68,152
-11% -$829K ﹤0.01% 1921
2024
Q3 		$7.87M Buy
607,245
+816
+0.1% +$10.9K ﹤0.01% 1753
2024
Q2 		$8.01M Buy
606,429
+38,120
+7% +$637K ﹤0.01% 1712
2024
Q1 		$13.4M Buy
568,309
+44,357
+8% +$1.1M ﹤0.01% 1420
2023
Q4 		$14.3M Buy
523,952
+177,695
+51% +$4.18M ﹤0.01% 1365
2023
Q3 		$9.4M Buy
346,257
+257,937
+292% +$6.38M ﹤0.01% 1514
2023
Q2 		$1.99M Sell
88,320
-2,089
-2% -$37.2K ﹤0.01% 2358
2023
Q1 		$1.02M Sell
90,409
-16,700
-16% -$213K ﹤0.01% 2605
2022
Q4 		$1.48M Sell
107,109
-23,682
-18% -$272K ﹤0.01% 2509
2022
Q3 		$1.44M Sell
130,791
-116,104
-47% -$1.48M ﹤0.01% 2566
2022
Q2 		$4M Buy
246,895
+56,467
+30% +$1.16M ﹤0.01% 2096
2022
Q1 		$5.27M Sell
190,428
-1,845
-1% -$56.4K ﹤0.01% 2033
2021
Q4 		$7.44M Sell
192,273
-41,476
-18% -$1.94M ﹤0.01% 1862
2021
Q3 		$11.8M Buy
233,749
+6,144
+3% +$317K ﹤0.01% 1666
2021
Q2 		$13.4M Sell
227,605
-22,019
-9% -$1.28M ﹤0.01% 1673
2021
Q1 		$14.6M Buy
249,624
+1,426
+0.6% +$96.4K ﹤0.01% 1553
2020
Q4 		$11.5M Sell
248,198
-37,263
-13% -$1.63M ﹤0.01% 1615
2020
Q3 		$9.63M Buy
285,461
+35,891
+14% +$1.16M ﹤0.01% 1556
2020
Q2 		$6.84M Buy
249,570
+47,023
+23% +$1.19M ﹤0.01% 1726
2020
Q1 		$3.72M Buy
202,547
+91,884
+83% +$2.1M ﹤0.01% 1879
2019
Q4 		$2.62M Sell
110,663
-1,200
-1% -$27.4K ﹤0.01% 2314
2019
Q3 		$2.46M Buy
111,863
+63,828
+133% +$1.78M ﹤0.01% 2315
2019
Q2 		$1.62M Buy
+48,035
New +$1.24M ﹤0.01% 2531

Other funds holding QTRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lionhunter Capital Management New York $222M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen's QTRX Position: Q2 2026 in Review

Nuveen increased its Quanterix (QTRX) stake by 224% in Q2 2026, buying an estimated $521K and bringing the position to 232,592 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2937.

Nuveen first reported a position in QTRX in Q2 2019 and has held it in 29 quarters since. The position peaked at $14.6M in Q1 2021. 133 funds tracked by Wall St. Rank hold QTRX as of Q2 2026.

  • Nuveen held 232,592 shares of Quanterix worth $1M as of Q2 2026.
  • Nuveen bought 160,750 Quanterix shares in Q2 2026, an estimated $521K.
  • Quanterix made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2937 holding.
  • Nuveen first reported a position in Quanterix in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Quanterix position peaked at $14.6M in Q1 2021.
  • 133 funds tracked by Wall St. Rank held Quanterix as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.